# GO_molecular_function_0000

[All 1,736 questions](../README.md) · [Method and limits](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **D** — serine-type endopeptidase inhibitor activity

| Expected-answer support | Reasoning versus lookup | Review status |
|---|---|---|
| supported | reasoning-supported | format-valid AI review |

These labels are Luna’s original judgments. Source support and reasoning from the original input are separate questions. The benchmark key and original score are unchanged.

## Complete original question

The sequence and choices below are the complete original user message, in their original order.

```text
[Protein Sequence]
MQRNILWISVVAAFGVFHFGECTYQDSGEDSSSMTEESRCDGPPHASRGLMNIPGWFYDGSRDQCRRYHFPDQQFDMAKNKFKTVTECRKSCRSTVPLQCFKKPPQTIRTMGLPVSTYNSTQGECVTIAVRPGQTGPNIFRREVECNETCRDPEYGKCAPLHIVDCGGSTGNHYNLDKQTCEKTTKNKCGPFATLEDCFKRCARYIQRKCNIPLLKSEYCDIVDLRYWYNSESKQCEEIMGCADDVYNFPTAKECWETCSSKEESRCLQPPDLGKLGIGRTRYYYNITSNRCLTTTHVAFWQNTEKKNNFKRRSDCENTCRPKHKDVKKL

[Multiple Choices]
A. tau protein binding
B. UDP-glucuronate decarboxylase activity
C. NADPH dehydrogenase activity
D. serine-type endopeptidase inhibitor activity
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Luna’s full visible review

### Expected-answer support: supported

> The matched protein has a UniProt GO annotation for serine-type endopeptidase inhibitor activity, but that annotation is computational (IEA), not direct experimental evidence for this GO term. The cited experimental function reports inhibition of coagulation-factor activation and notes no inhibition of the amidolytic activity of several tested proteases; this supports an inhibitory anticoagulant role while limiting claims about direct inhibition of those enzymes.

Cited evidence: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence has a likely N-terminal secretion signal and repeated cysteine-rich modules consistent with Kunitz domains, which are characteristic of extracellular protease inhibitors. That pattern favors D over the unrelated binding and metabolic-enzyme choices.

**Missing item-specific fact**

> The exact target and mechanism of this particular protein's inhibitory activity are item-specific and would require annotation or experimental information; they are not needed to favor D among these choices.

**Reason**

> The sequence provides a meaningful broad family-level clue that distinguishes the inhibitor option. Identifying the protein or recalling its database entry would add detail, but is not the sole basis for choosing D.

### Question ambiguity

**Multiple defensible options named by Luna:** none.

> D is the only choice aligned with the secreted, cysteine-rich inhibitor-like sequence. The experimental caveat concerns direct amidolytic inhibition of tested proteases, not a competing listed function.

### Important caveats

- The sequence matches the cited UniProt record, but the author’s exact annotation snapshot is unknown.
- The GO annotation is computationally assigned; the cited experimental description supports an anticoagulant inhibitory role but does not establish direct inhibition of the amidolytic activity of the listed proteases.

<details>
<summary>Saved visible review as JSON</summary>

```json
{
  "case_id": "GO_molecular_function_0000",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched protein has a UniProt GO annotation for serine-type endopeptidase inhibitor activity, but that annotation is computational (IEA), not direct experimental evidence for this GO term. The cited experimental function reports inhibition of coagulation-factor activation and notes no inhibition of the amidolytic activity of several tested proteases; this supports an inhibitory anticoagulant role while limiting claims about direct inhibition of those enzymes.",
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H4"
    ]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence has a likely N-terminal secretion signal and repeated cysteine-rich modules consistent with Kunitz domains, which are characteristic of extracellular protease inhibitors. That pattern favors D over the unrelated binding and metabolic-enzyme choices.",
    "missing_item_specific_fact": "The exact target and mechanism of this particular protein's inhibitory activity are item-specific and would require annotation or experimental information; they are not needed to favor D among these choices.",
    "reason": "The sequence provides a meaningful broad family-level clue that distinguishes the inhibitor option. Identifying the protein or recalling its database entry would add detail, but is not the sole basis for choosing D."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "D is the only choice aligned with the secreted, cysteine-rich inhibitor-like sequence. The experimental caveat concerns direct amidolytic inhibition of tested proteases, not a competing listed function."
  },
  "important_caveats": [
    "The sequence matches the cited UniProt record, but the author’s exact annotation snapshot is unknown.",
    "The GO annotation is computationally assigned; the cited experimental description supports an anticoagulant inhibitory role but does not establish direct inhibition of the amidolytic activity of the listed proteases."
  ]
}
```

</details>

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**This source material was supplied only to the reviewer. It was absent from the original evaluated question.** An exact-sequence database match can support a key without establishing that the question can be answered by reasoning from its original input.

**Accession:** `Q8MVC4`; identity was recovered from dataset image-path metadata and was absent from the evaluated model input.  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; selected entry version 74. The exact author source snapshot remains unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8MVC4.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:23.101573+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"15116248","source":"PubMed"}],"value":"Anticoagulant protein that inhibits the activation of host coagulation factors Xa (F10) and IXa (F9) by the factor VIIa-tissue factor (F7-F3) complex (PubMed:15116248). Does not inhibit the amidolytic activity of thrombin (F2), factor Xa (F10), trypsin and elastase (PubMed:15116248)"}]}
```

Source SHA-256: `422cacae32c00e928adbf4a5309d527434b905851eeaa0c16ad8bfacaca85328`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8MVC4.json)  
**Locator:** `/uniProtKBCrossReferences/10`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:23.101573+00:00.  

```json
{"database":"GO","id":"GO:0004867","properties":[{"key":"GoTerm","value":"F:serine-type endopeptidase inhibitor activity"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `422cacae32c00e928adbf4a5309d527434b905851eeaa0c16ad8bfacaca85328`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8MVC4?format=txt&versions=74)  
**Locator:** `lines 30-34`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 74 / 1.  
**Retrieved:** 2026-11-02T04:32:29.047638+00:00.  

```text
CC   -!- FUNCTION: Anticoagulant protein that inhibits the activation of host
CC       coagulation factors Xa (F10) and IXa (F9) by the factor VIIa-tissue
CC       factor (F7-F3) complex (PubMed:15116248). Does not inhibit the
CC       amidolytic activity of thrombin (F2), factor Xa (F10), trypsin and
CC       elastase (PubMed:15116248). {ECO:0000269|PubMed:15116248}.
```

Source SHA-256: `64b48644632e51cc398a0e6a4a41747feaeeafbddeb8bb3617a19726afe3c707`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8MVC4?format=txt&versions=74)  
**Locator:** `lines 54-54`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 74 / 1.  
**Retrieved:** 2026-11-02T04:32:29.047638+00:00.  

```text
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
```

Source SHA-256: `64b48644632e51cc398a0e6a4a41747feaeeafbddeb8bb3617a19726afe3c707`.

---

Question and key: [LiveProteinBench source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json) (zero-based source row 0). Benchmark content © 2026 LiveProteinBench contributors, [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). Cited UniProt / Gene Ontology excerpts retain their own attribution; see [source credits](../THIRD_PARTY_NOTICES.md).
